Adewunmi Akingbola

Adewunmi Akingbola

Auto-generated profile, based on publicly available information

Adewunmi Akingbola

Department of Public Health, University of Cambridge, Cambridge, England, UK

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2024 in Journal of Medicine, Surgery, and Public Health
Verified
Journal Article
Open access
AAAdewunmi Akingbola
Adewunmi Akingbola
OAOluwatimilehin Adeleke
Oluwatimilehin Adeleke
AIAyotomiwa Idris
Ayotomiwa Idris
OAOlajumoke Adewole
Olajumoke Adewole
AAAbiodun Adegbesan
Abiodun Adegbesan

27 September 2024 in Journal of Medicine, Surgery, and Public Health
Verified
Journal Article
Open access
AAAbiodun Adegbesan
Abiodun Adegbesan
AAAdewunmi Akingbola
Adewunmi Akingbola
OAOlusola Aremu
Olusola Aremu
OAOlajumoke Adewole
Olajumoke Adewole
JAJohn Chukwuemeka Amamdikwa
John Chukwuemeka Amamdikwa
USUchechukwu Shagaya
Uchechukwu Shagaya

10 August 2024 in Journal of Medicine, Surgery, and Public Health
Verified
Journal Article
Open access
AAAdewunmi Akingbola
Adewunmi Akingbola
AAAbiodun Adegbesan
Abiodun Adegbesan
OOOlajide Ojo
Olajide Ojo
JOJessica Urowoli Otumara
Jessica Urowoli Otumara
UAUthman Hassan Alao
Uthman Hassan Alao

3 April 2025 in Tropical Medicine and Health
Verified
Journal Article
Open access
PDF file
AAAdewunmi Akingbola
Adewunmi Akingbola
CAChristopher Abiodun Adegbesan
Christopher Abiodun Adegbesan
OAOlajumoke Adewole
Olajumoke Adewole
CICourage Idahor
Courage Idahor
TOTolani Odukoya
Tolani Odukoya
PMPetra Mariaria
Petra Mariaria
Mpox has re-emerged as a significant public health threat, particularly in Africa. This study explores the key drivers behind the recent resurgence, focusing on epidemiological trends, transmission dynamics, and lessons learned from recent outbreaks. The research involved a comprehensive review of recent mpox outbreaks, analyzing factors, such as socio-economic conditions, environmental influences, and genetic evolution. Findings indicate that the resurgence is linked to the cessation of smallpox vaccination, increased human–wildlife interactions, and rapid urbanization in endemic regions. The virus, which was previously confined to rural areas, has now spread to urban populations, and crossed national borders, driven by high population mobility and socio-economic instability. A notable shift in transmission dynamics has been observed, with increased human-to-human transmission, particularly among men who have sex with men (MSM), contributing to more severe and widespread outbreaks. The study highlights the urgent need to strengthen health systems in Africa, particularly in the areas of diagnostics, surveillance, and public health preparedness. Challenges such as inadequate laboratory infrastructure and delayed response mechanisms have exposed vulnerabilities in current public health frameworks. To prevent future outbreaks, targeted strategies must be implemented, including enhanced community engagement, improved access to vaccines and treatments, and timely, accurate reporting of cases. Coordinated global action is essential to prevent mpox from becoming a more persistent and widespread public health threat. This research discusses the importance of proactive measures and international cooperation in addressing the ongoing threat posed by mpox, particularly in regions with limited healthcare resources.

26 November 2024 in Journal of Medicine, Surgery, and Public Health
Verified
Journal Article
Open access
AAAbiodun Adegbesan
Abiodun Adegbesan
AAAdewunmi Akingbola
Adewunmi Akingbola
OOOlajide Ojo
Olajide Ojo
OJOtumara Urowoli Jessica
Otumara Urowoli Jessica
UAUthman Hassan Alao
Uthman Hassan Alao
OAOwolabi Abdullahi
Owolabi Abdullahi

25 January 2025 in Infectious Diseases
Verified
Journal Article
Closed access
AAAdewunmi Akingbola
Adewunmi Akingbola
AAAbiodun Adegbesan
Abiodun Adegbesan
Samuel TundealaoSamuel Tundealao
Samuel Tundealao
OAOlajumoke Adewole
Olajumoke Adewole
CAComfort Ayikoru
Comfort Ayikoru
JCJoel Chuku
Joel Chuku
Human Metapneumovirus (HMPV) is a re-emerging respiratory pathogen causing significant morbidity and mortality, particularly among young children, the elderly, and immunocompromised individuals. First identified in 2001, HMPV has since been recognised as a leading cause of acute respiratory tract infections (ARTIs) worldwide. Its transmission occurs through droplets, direct contact, and surface contamination, with crowded spaces and healthcare facilities serving as key environmental amplifiers. HMPV's clinical manifestations, ranging from mild cold-like symptoms to severe pneumonia, often overlap with those of other respiratory pathogens like RSV and COVID-19, complicating timely diagnosis and management. Despite advancements in molecular diagnostics, the limited accessibility of these tools in low-resource settings presents a challenge. Preventive measures, such as hygiene practices and physical distancing, remain critical, as no approved vaccines or targeted antiviral therapies are currently available. However, promising innovations, including AI-guided vaccine design and portable diagnostic tools, highlight the potential for future breakthroughs. This article highlights the urgent need for enhanced surveillance, scalable diagnostics, and intensified research into vaccines and therapeutic strategies. By addressing these gaps, HMPV's global burden can be significantly mitigated, improving outcomes for high-risk populations, and strengthening preparedness against respiratory virus outbreaks.